Significant association between the tau gene A0/A0 genotype and Parkinson's disease

Annals of Neurology

Volumn 47, Issue 2, 2000, Pages 242-245

  Pastor, Pau ^a   Ezquerra, Mario ^a   Muñoz, Esteban ^a   Martí, María José ^a   Blesa, Rafael ^a   Tolosa, Eduard ^a   Oliva, Rafael ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ADULT; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

AGED; ALLELES; ALZHEIMER DISEASE; DINUCLEOTIDE REPEATS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTRONS; MALE; MENTAL HEALTH; MIDDLE AGED; PARKINSON DISEASE; REFERENCE VALUES; TAU PROTEINS;

EID: 0033951680     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200002)47:2<242::AID-ANA16>3.0.CO;2-L     Document Type: Article

References (20)

1. Conrad C, Andreadis A, Trojanowsky JQ, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997;41:277-281
2. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-715
3. Oliva R, Tolosa E, Ezquerra M, et al. Significant changes in the σ A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch Neurol 1998;55: 1122-1124
4. Wisniewski K, Jervis GA, Moretz RC, Wisniewski HM. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol 1979;5:288-294
5. Vermersch P, Delacourte A, Javoy-Agid F, et al. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins. Ann Neurol 1993;33:445-450
6. Perl DP, Olanow CW, Calne D. Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol 1998;44(Suppl 1):S19-S31
7. Rajput AH, Uitti RJ, Stidhakar S, Rozdilsky B. Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Ann Neurol 1989;25:602-606
8. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752
9. Marder K, Tang MX, Mejia H, et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996;47:155-160
10. Muñoz E, Obach V, Oliva R, et al. α1-Antichymotrypsin gene polymorphism and susceptibility to Parkinson's disease. Neurology 1999;52:297-301
11. Weiner WJ, Lang AE. Appendix. In: Movement disorders: a comprehensive survey. New York: Futura Publishing, 1989: 687-725
12. McKhann G, Drackman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group. Neurology 1984;34:939-944
13. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146
14. Lazzarini AM, Golhe LI, Dennis NJ, et al. Tau intronic polymorphism in Parkinson's disease and progressive supranuclear palsy. Neurology 1997;48:A427 (Abstract)
15. Morris HK, Janssen JC, Bandmann O, et al. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry 1999;66:665-667
16. Galloway PG, Bergeron C, Perry G. The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson's disease. Neurosci Lett 1989;100:6-10
17. Hutton M, Lendon CL, Rizzu P. et al. Association of a missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705
18. Poorkaj P, Bird T, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-825
19. Heutink P, Stevens M, Rizzu P, et al. Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families. Ann Neurol 1997;41:150-159
20. Wilhelmsen KC, Lynch E, Pavlou M, et al. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 1994;55:1159-1165